Ultrasonographic Response to Cervical and Upper Thoracic SNAG in Medial Epicondylitis, Randomized Clinical Trial

NCT ID: NCT07187102

Last Updated: 2025-09-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-08

Study Completion Date

2025-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim of the work :

1. To detect if there is any change would occur in the neovascularity and echogenicity after using cervical and upper thoracic SNAG or not in ME patients.
2. To find the effect of cervical and upper thoracic SNAG on pain, function of upper extremities, grip strength in ME comparing with traditional treatment alone

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

medial epicondylitis(ME) of the elbow is a condition characterized by aggravation of pain in the outer part of the elbow during active wrist flexion , and presentation of pain on direct palpation of the medial epicondyle, or proximal muscle belly . Biomechanical and sensorimotor deficits can occur and adversely impact upper extremity function .These functional deficits may interfere with occupational tasks and activities of daily living The study's results: Measuring the changes that will be produced by using therapeutic growth of the cervical and thoracic vertebrae on the pathological changes that persist in the tendons of the tens of the tibialis cruciate ligaments in detecting excess weight resulting from the disease of the middle epicondyle, such as increased blood vessels in the tendon and decreased echogenicity of the tendon, in addition to measuring the changes that occurred in the extent of pain sensation and the extent of functional performance of the shoulder and elbow joints. Patients will be directly selected jointly according to the patient's specifications for the research and written consent will be obtained from the patient after a detailed explanation of the research steps and what is required of him. The vocal function of the tendon will be evaluated, with the exception of functional pain of the successful upper extremity and the strength of the hand muscles before and after the experiment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medial Epicondylitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

one group receive SNAG plus traditional treatment second group receive traditional treatment
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Open Label - both participants and investigators will be aware of the intervention received

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

experimental group

Participants will receive the physiotherapy SNAG plus traditional treatment program (4weeks, supervised sessions 3 times per week )

Group Type EXPERIMENTAL

SNAG ( sustained natural apopheseal glide )

Intervention Type OTHER

SNAG : type of mobilization of vertebral coulmn

control group

Participants will receive the physiotherapy traditional treatment program (4weeks, supervised sessions 3 times per week )

Group Type OTHER

SNAG ( sustained natural apopheseal glide )

Intervention Type OTHER

SNAG : type of mobilization of vertebral coulmn

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SNAG ( sustained natural apopheseal glide )

SNAG : type of mobilization of vertebral coulmn

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ranges from 35 to 50 years old in both sexes.
* Patients with LE that diagnosed by orthopedist.
* Pain onset is more than 3 months appear primarily with use or rest or in both, also , it appear with deep palpation of the medial epicondyle .

Exclusion Criteria

* • Rheumatoid Arthritis .

* Skin infection.
* History of previous elbow surgery.
* Any pathology in the shoulder joint.
* Neurologic deficit in upper extremity.
* Cervical disc prolapse and radiculopathy C5,6.
* Dislocation of elbow joint.
* Recent fractures of upper extremity.
* Arthrosis of the radiohumeral joint.
* Osteochondritis dissecans.
* Osteonecrosis.
* Plica synovialis.
* Participants receiving other treatment, in the form of physical therapy or medication, for the duration of the study that may interfere with the results of this study.
Minimum Eligible Age

35 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beni-Suef University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sahar Mowad Abdelmutilibe

faculty of physical therapy , beni suef university

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Physical Therapy, Beni-Suef University

Banī Suwayf, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sahar M Abdelmutilibe, PHD

Role: CONTACT

0021027620061

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sahar M Abdelmutilibe

Role: primary

0021027620061

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FMBSUREC/07092025/Ahmed

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.